scholarly journals Inequalities in pharmacologic treatment of spasticity in Sweden – health economic consequences of closing the treatment gap

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Annabelle Forsmark ◽  
Linda Rosengren ◽  
Per Ertzgaard
Stroke ◽  
2019 ◽  
Vol 50 (Suppl_1) ◽  
Author(s):  
Aravind Ganesh ◽  
Ramon Luengo-Fernandez ◽  
Sarah T Pendlebury ◽  
Peter M Rothwell ◽  

2021 ◽  
Vol 30 (16) ◽  
pp. S22-S30
Author(s):  
Jane Fellows ◽  
David Voegeli ◽  
Jonas Håkan-Bloch ◽  
Nana Overgaard Herschend ◽  
Zenia Størling

Background: Peristomal skin complications (PSCs) impair life for people with an ostomy. Visual signs of PSCs include discolouration, but sensation symptoms like pain, itching, and burning are equally important and underreported. Aim: To provide improved understanding of PSC prevalence and associated challenges in the communities of ostomy patients and ostomy care nurses. Methods: The Ostomy Life Study 2019 encompassed a patient survey (completed by 5187 people with an ostomy) and a nurse survey (completed by 328 ostomy care nurses). Findings: In total, 88% of patients experienced PSCs and 75% experienced PSC symptoms in the absence of discolouration. Eighty per cent of nurses considered ostomy-related issues to be the main reason for PSCs, and a correlation between PSC severity and number of nurse consultations was demonstrated. Conclusion: This study revealed a remarkably high PSC incidence in the absence of discolouration and highlighted direct consequences of having compromised skin and the health-economic consequences.


2017 ◽  
Vol 17 (3) ◽  
pp. 249-265 ◽  
Author(s):  
Pieter T. de Boer ◽  
Britt M. van Maanen ◽  
Oliver Damm ◽  
Bernhard Ultsch ◽  
Franklin C.K. Dolk ◽  
...  

2020 ◽  
Author(s):  
Petter Olsson ◽  
Carl Sköder ◽  
Lars Ahlbeck ◽  
Frida Hjalte ◽  
Karl-Olof Welin ◽  
...  

Abstract BackgroundThe aim of this cross-sectional survey was to compare the health-economic consequences for allergic rhinitis (AR) patients treated with sublingual Immunotherapy (SLIT) in terms of direct and indirect costs with a reference population of patients receiving standard of care pharmacological therapy. MethodsPrimary objective was to analyse the health-economic consequences of SLIT for grass pollen allergy in Sweden vs reference group waiting for subcutaneous immunotherapy (SCIT). A questionnaire was mailed to two groups of AR patients. ResultsThe questionnaire was distributed to 548 patients, 307 with SLIT and 241 in reference group (waiting for SCIT). Response rate was 53.8%. Mean annual costs were higher for reference patients than SLIT group; € 3907 (SD 4268) vs € 2084 (SD 1623) p < 0.001. Mean annual direct cost was higher for SLIT-patients, € 1191 (SD 465) than for reference, € 751 (SD 589) p< 0.001. Mean annual indirect costs for combined absenteeism and presenteeism were lower for patients treated with SLIT, € 912 (SD 1530), than for reference, € 3346 (SD 4120) p< 0.001, with presenteeism as main driver.ConclusionsSLIT seems to be a cost-beneficial way to treat seasonal AR. This information might be used to guide future recommendations.


2021 ◽  
Vol 14 (4) ◽  
pp. 105-108
Author(s):  
Alexander Baklanov ◽  
Natalia E. Chubarova ◽  
Vladimir A. Kolosov ◽  
Svetlana M. Malkhazova ◽  
Boris N. Porfiriev

The COVID-19 pandemic has severely affected all countries and the global scientific agenda, particularly that of health, economy, environment, geography and geosciences in general. This Special Issue is also a contribution to the global efforts of the scientific community in the analysis of the geography of the COVID-19 pandemic with public health, economic and environmental consequences. Two blocks of papers are considered: (1) the socio-spatial, statistical and geographical analysis of COVID-19 distributions; and (2) the impacts of the pandemic lockdown on the environment, air pollution, and the quality of water.


2004 ◽  
Vol 39 (Supplement_2) ◽  
pp. S132-S139 ◽  
Author(s):  
Gunnel Ragnarson Tennvall ◽  
Jan Apelqvist

Sign in / Sign up

Export Citation Format

Share Document